GI
ALXN

Gradient Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Gradient Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5
Closed -$1K – 1301
2021
Q1 		$1K Hold
5
– – ﹤0.01% 1133
2020
Q4 		$1K Hold
5
– – ﹤0.01% 1112
2020
Q3 		$1K Sell
5
-19
-79% -$2.05K ﹤0.01% 1116
2020
Q2 		$3K Sell
24
-183
-88% -$19.4K ﹤0.01% 858
2020
Q1 		$19K Sell
207
-10,621
-98% -$1.04M ﹤0.01% 541
2019
Q4 		$1.17M Buy
10,828
+1,769
+20% +$189K 0.05% 191
2019
Q3 		$887K Buy
9,059
+1,493
+20% +$168K 0.04% 201
2019
Q2 		$991K Buy
7,566
+3,064
+68% +$395K 0.05% 189
2019
Q1 		$609K Sell
4,502
-1,674
-27% -$208K 0.04% 170
2018
Q4 		$601K Sell
6,176
-2,080
-25% -$246K 0.04% 173
2018
Q3 		$1.15M Buy
8,256
+2,242
+37% +$281K 0.06% 147
2018
Q2 		$747K Buy
6,014
+1,754
+41% +$205K 0.04% 171
2018
Q1 		$475K Buy
4,260
+895
+27% +$107K 0.03% 189
2017
Q4 		$402K Buy
3,365
+791
+31% +$96.3K 0.02% 207
2017
Q3 		$361K Buy
2,574
+19
+0.7% +$2.58K 0.02% 195
2017
Q2 		$311K Buy
2,555
+189
+8% +$22K 0.02% 194
2017
Q1 		$287K Sell
2,366
-197
-8% -$25.4K 0.02% 175
2016
Q4 		$314K Buy
2,563
+445
+21% +$54.5K 0.03% 153
2016
Q3 		$260K Buy
2,118
+106
+5% +$13.6K 0.03% 172
2016
Q2 		$235K Sell
2,012
-136
-6% -$19.3K 0.03% 172
2016
Q1 		$299K Buy
+2,148
New +$315K 0.04% 147

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Gradient Investments's ALXN Position: Q2 2021 in Review

Gradient Investments sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 5 shares — an estimated $1K sold.

Gradient Investments first reported a position in ALXN in Q1 2016 and held it in 21 quarters. The position peaked at $1.17M in Q4 2019. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Gradient Investments reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Gradient Investments sold 5 Alexion Pharmaceuticals shares in Q2 2021, an estimated $1K.
  • Gradient Investments first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 21 quarters.
  • Gradient Investments's Alexion Pharmaceuticals position peaked at $1.17M in Q4 2019.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Gradient Investments's 13F filing for Q2 2021, filed 12 Jul 2021.